Latest News: Piramal Pharma Gets 3 USFDA Observations at US FacilityEli Lilly pauses Indian obesity awareness campaign after regulatory noticesKota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take BodiesICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?Patient dies after oxygen supply stops in ambulanceIndiaAI, ICMR sign MoU to advance AI in healthcareIllegal drug manufacturing racket busted in Baddi areaUS FDA and Telangana DCA bolster global pharma safety at second regulatory forumNishant as Health Minister, Bihar is all set to witness a New Dawn of HealthcareSix Women Develop Serious Complications After C-SectionCracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses DetectedIndian Pharma Majors Plan to Invest in USEmcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 crFake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED ProbeA SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular IntercontinentalNational Pharmaceutical Pricing Authority notifies retail price of 42 new drugsWorld’s First Malaria Treatment for Newborns and Young Infants Receives WHO PrequalificationFIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged DocumentsLaughing all the Way to Health with Sir Ganga Ram HospitalSemaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik JonssonPak-made illegal cosmetics recovered from Itwari shopLicences of 20 medical stores suspended after inspectionsBain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 croreSun Pharma to acquire U.S. firm Organon in $11.75 billion dealHP accounts for 47 inferior drugs in March alertCivil society group SAM calls for greater transparency involving clinical trialsDifferent packaging, typos expose fake Mounjaro racketTo Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this BookNCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 croreRajasthan Bans 7 Sub-Standard MedicinesONESOURCE’s partner receives USFDA tentative approval for Semaglutide InjectionAjanta Pharma gets USFDA Form 483 with five observations at Paithan plantObesity drug market to gain as Indians pop the pill and Chinese bring moreAurobindo Pharma Rs 800 Cr Buyback Opens Apr 23Boehringer Ingelheim launches AI centre for pharma research in LondonPharma exports rose 2% to over $31 billion in FY26 despite sharp decline in MarchCentre Urges States To Enforce Clinical Establishments Act & Standardise Hospital RatesPiramal, Ajinomoto team on ADC development and manufacturingAurobindo Pharma Gets USFDA Nod for Glycerol LiquidCancer cure must not be hostage to Big PharmaGLP-1 drugs emerge as a new option for Indian women bat­tling PCOSAurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral LiquidLegal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In IndiaPatna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS ActCOMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s PatientsDelhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One ArrestedFDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug DevelopmentIPC releases draft NFI-2026 to promote rational use of medicinesMoonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic SurgeryUS market to dent India pharma earnings even as domestic growth remains firmBiocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mgHealthcare, pharma sector to create 2-2.5 million new jobs by 2030Over 45% eye infection bacteria drug-resistant, study flags AMR threatLokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across KarnatakaAlembic Pharma Gets USFDA Nod for DapagliflozinOn World Health Day ‘CAHO Na Patient Se Pyaar Hai’Supreme Court willing to understand Angst of Doctors regarding Consumer Protection ActAurobindo Pharma Board approves ₹800 cr share buyback planThree held for cheating SCB Hospital patients on promise of arranging bloodNATHEALTH resolves to evolve to fit The Bill of Viksit BharatCancer drug makers seek 50% price hike as platinum surge hits production viabilityCDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & developmentDelhi Police busts racket diverting govt-supplied medicines for private sale; 3 heldNiti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of BusinessLaser rescued an Imperiled Food Pipe in Sir Ganga Ram HospitalCentre gives custom cushion to supply strained Pharma, MedTech manufacturersDelhi man arrested for running online racket selling counterfeit Ayurvedic productsCustoms Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care3-month relief: Final call for 10,000 pharmacists to renew registrationMarksans Pharma gets USFDA nod for generic Benzonatate capsulesGreatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening testHaryana Mandates Real-Time Medicine Tracking In Govt HospitalsParliamentary Panel Recommends Decentralisation Of Approval Of All Medical DevicesDiabetic drug metformin found to act on brainHetero debuts semaglutide generic in emerging marketsLB Pharma Begins Pivotal Phase 3 Schizophrenia TrialCheck manufacturing, sale of 26 unapproved drugs, central regulator tells state authorityStem cell therapy for autism illegal: NMC advisoryIndia’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing FrameworkDelhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s OzempicNPPA allows 0.64% hike in MRP of essential drugs in line with WPI riseGovt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya SabhaRegulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS24-year-old woman dies during surgery; Five UP doctors booked for negligenceExtortion, Fake Medicines: The Fall Of Surat’s Yoga GuruTaisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran WarDCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central ApprovalIndia’s drug body flags 90 unapproved FDC medicines, states told to take actionIndia advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra SinghUnapproved drops for dry eyes pose risks: GovtSemaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot ForwardGovt highlights multi-layer framework to curb misleading advertisementsMajor breakhthrough: Sonbhadra cops nab codeine syrup racket handler in BengalStudy finds rising resistance to a last-resort antibiotic in AfricaPatna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
May 14, 2026
Latest News: Piramal Pharma Gets 3 USFDA Observations at US FacilityEli Lilly pauses Indian obesity awareness campaign after regulatory noticesKota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take BodiesICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?Patient dies after oxygen supply stops in ambulanceIndiaAI, ICMR sign MoU to advance AI in healthcareIllegal drug manufacturing racket busted in Baddi areaUS FDA and Telangana DCA bolster global pharma safety at second regulatory forumNishant as Health Minister, Bihar is all set to witness a New Dawn of HealthcareSix Women Develop Serious Complications After C-SectionCracks Down on Pharma Biological Firm in Bagru; Labeling Violations, Unapproved Claims and Quality Lapses DetectedIndian Pharma Majors Plan to Invest in USEmcure Pharmaceuticals Q4 net profit rises 24% to ₹243.74 crFake Cancer Drug Racket: Delhi HC Grants Bail, Flags Gaps in ED ProbeA SSi Mantra fame Robotic Telesurgery Champion pulls off another Spectacular IntercontinentalNational Pharmaceutical Pricing Authority notifies retail price of 42 new drugsWorld’s First Malaria Treatment for Newborns and Young Infants Receives WHO PrequalificationFIR Lodged Against Pharmacist in Chandauli for Working Nearly 10 Years on Forged DocumentsLaughing all the Way to Health with Sir Ganga Ram HospitalSemaglutide generics ‘stimulating’ Obesity market growth, says Eli Lilly’s Patrik JonssonPak-made illegal cosmetics recovered from Itwari shopLicences of 20 medical stores suspended after inspectionsBain Capital sells nearly 1 pc stake in Emcure Pharma for Rs 289 croreSun Pharma to acquire U.S. firm Organon in $11.75 billion dealHP accounts for 47 inferior drugs in March alertCivil society group SAM calls for greater transparency involving clinical trialsDifferent packaging, typos expose fake Mounjaro racketTo Eat or not to Eat, if this Dilemma is ‘Eating’ you, ‘Eat’ this BookNCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 croreRajasthan Bans 7 Sub-Standard MedicinesONESOURCE’s partner receives USFDA tentative approval for Semaglutide InjectionAjanta Pharma gets USFDA Form 483 with five observations at Paithan plantObesity drug market to gain as Indians pop the pill and Chinese bring moreAurobindo Pharma Rs 800 Cr Buyback Opens Apr 23Boehringer Ingelheim launches AI centre for pharma research in LondonPharma exports rose 2% to over $31 billion in FY26 despite sharp decline in MarchCentre Urges States To Enforce Clinical Establishments Act & Standardise Hospital RatesPiramal, Ajinomoto team on ADC development and manufacturingAurobindo Pharma Gets USFDA Nod for Glycerol LiquidCancer cure must not be hostage to Big PharmaGLP-1 drugs emerge as a new option for Indian women bat­tling PCOSAurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral LiquidLegal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In IndiaPatna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS ActCOMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s PatientsDelhi Crime Branch Seizes Huge Stock Of Expired Baby Food, Cosmetics; One ArrestedFDA Releases Draft Guidance To Validate Non-Animal Testing Methods (NAMs) In Drug DevelopmentIPC releases draft NFI-2026 to promote rational use of medicinesMoonshot, SS Innovations displayed Battle Readiness for Monumental Goals in Robotic SurgeryUS market to dent India pharma earnings even as domestic growth remains firmBiocon Pharma receives USFDA approval for Dapagliflozin Tablets, 5 mg and 10 mgHealthcare, pharma sector to create 2-2.5 million new jobs by 2030Over 45% eye infection bacteria drug-resistant, study flags AMR threatLokayukta Police Launch Multi-City Raids on ADC; Rs 3.37 Crore in Disproportionate Assets Unearthed Across KarnatakaAlembic Pharma Gets USFDA Nod for DapagliflozinOn World Health Day ‘CAHO Na Patient Se Pyaar Hai’Supreme Court willing to understand Angst of Doctors regarding Consumer Protection ActAurobindo Pharma Board approves ₹800 cr share buyback planThree held for cheating SCB Hospital patients on promise of arranging bloodNATHEALTH resolves to evolve to fit The Bill of Viksit BharatCancer drug makers seek 50% price hike as platinum surge hits production viabilityCDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & developmentDelhi Police busts racket diverting govt-supplied medicines for private sale; 3 heldNiti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of BusinessLaser rescued an Imperiled Food Pipe in Sir Ganga Ram HospitalCentre gives custom cushion to supply strained Pharma, MedTech manufacturersDelhi man arrested for running online racket selling counterfeit Ayurvedic productsCustoms Duty Exemption on Petrochemicals, AiMeD welcomes but Dil ‘Mange More’Sir Ganga Ram Hospital Launches Dialysis Center in Gurgaon for advanced care3-month relief: Final call for 10,000 pharmacists to renew registrationMarksans Pharma gets USFDA nod for generic Benzonatate capsulesGreatest Defender of Consumer Rights doesn’t like Sound of Patient as ‘GRAHAK’Roche launches the cobas MPX-E assay, a new 4-in-1 donor screening testHaryana Mandates Real-Time Medicine Tracking In Govt HospitalsParliamentary Panel Recommends Decentralisation Of Approval Of All Medical DevicesDiabetic drug metformin found to act on brainHetero debuts semaglutide generic in emerging marketsLB Pharma Begins Pivotal Phase 3 Schizophrenia TrialCheck manufacturing, sale of 26 unapproved drugs, central regulator tells state authorityStem cell therapy for autism illegal: NMC advisoryIndia’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing FrameworkDelhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s OzempicNPPA allows 0.64% hike in MRP of essential drugs in line with WPI riseGovt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya SabhaRegulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS24-year-old woman dies during surgery; Five UP doctors booked for negligenceExtortion, Fake Medicines: The Fall Of Surat’s Yoga GuruTaisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran WarDCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central ApprovalIndia’s drug body flags 90 unapproved FDC medicines, states told to take actionIndia advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra SinghUnapproved drops for dry eyes pose risks: GovtSemaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot ForwardGovt highlights multi-layer framework to curb misleading advertisementsMajor breakhthrough: Sonbhadra cops nab codeine syrup racket handler in BengalStudy finds rising resistance to a last-resort antibiotic in AfricaPatna: Over 20,000 Banned Injections Seized in Ramkrishna Nagar Area, One Arrested
May 14, 2026

ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

OneSource Speciality Pharma announced that its partner Orbicular Pharmaceutical Technologies (Orbicular), together with its U.S.-based front-end partner (the ANDA holder), has secured tentative U.S. Food and Drug Administration (FDA) approval for an Abbreviated New Drug Application (ANDA) for a generic version of Ozempic (Semaglutide Injection).

OneSource is the contract development and manufacturing organization (CDMO) partner for this product. This milestone highlights a closely integrated development-to-submission model: Orbicular led the product development and technical program for this complex peptide, while OneSource supported the program as the CDMO partner, providing end-to-end manufacturing capabilities for the U.S. market filing. The collaboration is designed to ensure reliable commercial supply from OneSource’s US-FDA approved flagship site in Bangalore.

Neeraj Sharma, CEO & MD, OneSource Speciality Pharma, speaking on the development, said: We are pleased to announce that our partner Orbicular, along with its front-end partner (the ANDA holder), has received tentative approval for a generic version of Ozempic (Semaglutide Injection). This milestone reflects Orbicular’s scientific expertise and OneSource’s CDMO capabilities, supported by our US-FDA approved manufacturing site.

admin

Related Posts

Piramal Pharma Gets 3 USFDA Observations at US Facility
Piramal Pharma Gets 3 USFDA Observations at US Facility

New Delhi: Piramal Pharma Limited has informed stock exchanges that the United States Food and Drug Administration (US FDA) conducted a Good Manufacturing Practices (GMP) inspection at the company’s Sellersville…

Continue reading
Eli Lilly pauses Indian obesity awareness campaign after regulatory notices
Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly has paused an obesity awareness campaign in India in response to a regulatory notice regarding advertising rules for prescription medicines, Reuters reports. In March, India’s Central Drugs Standard…

Continue reading

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

Kota: Uproar After 4 Women Die in Government Hospital; Relatives Refuse to Take Bodies

ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

ICMR transfers three Indigenous Medical Technologies to Industry at National Technology Day 2026

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Will ‘Epidemic’ of Bridge Collapse in Bihar halt with new Minister in?

Patient dies after oxygen supply stops in ambulance

Patient dies after oxygen supply stops in ambulance